Status:
COMPLETED
Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
Lead Sponsor:
Gachon University Gil Medical Center
Conditions:
Hypertension
Eligibility:
All Genders
25-75 years
Phase:
PHASE4
Brief Summary
The investigators hypothesized combination therapy would be superior to monotherapy.
Eligibility Criteria
Inclusion
- Hypertension
Exclusion
- Chronic renal disease
- Severe hypertension
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00741078
Start Date
December 1 2004
End Date
August 1 2008
Last Update
August 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gil Medical Center
Incheon, South Korea, 405-760